Bioline Rx reported $39.8M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Arca Biopharma USD 488.62M 20.63M Dec/2025
Bio Path USD 690K 56K Sep/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Capricor Therapeutics USD 355.95M 229.51M Dec/2025